Beipiao Central Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Beijing Tiantan Hospital1 trial
• Shanghai Hutchison Pharmaceuticals Limited1 trial

Closed trials

• Completed

  Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke

  NCT06202378· Phase 2· Shanghai Hutchison Pharmaceuticals Limited· Source

• Completed

  Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

  NCT06429384· Phase 2· Beijing Tiantan Hospital· Source